Cerus Corp (CERS) Posts Q2 EPS Loss of $0.13
Get Alerts CERS Hot Sheet
Join SI Premium – FREE
Cerus Corp (NASDAQ: CERS) reported Q2 EPS of ($0.13), $0.03 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $6.8 million versus the consensus estimate of $6.97 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerus (CERS) Tops Q3 EPS by 2c, offers product revenue guidance
- aTyr Pharma (LIFE) Reports Q3 EPS of $0.53; Offers Guidance
- Calix, Inc. (CALX) Tops Q3 EPS by 3c; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share